On 2025-08-14, Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) announced earnings per share of $-0.36 for the fiscal quarter ending 2025-06-30, beating the average analyst estimate of $-0.80.
The next expected annoucement date for quarterly earnings is 2025-11-13, with an average estimated earnings per share of $-0.20 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-14 | 2025-06-30 | $-0.80 | $-0.36 |
| 2025-05-15 | 2025-03-31 | $-0.80 | $-0.56 |
| 2025-03-03 | 2024-12-31 | $-0.80 | $-0.64 |
| 2024-11-14 | 2024-09-30 | $-0.80 | $-0.80 |
| 2024-08-21 | 2024-06-30 | $-0.80 | $-1.04 |
| 2024-05-09 | 2024-03-31 | $-0.80 | $-1.12 |
| 2024-03-07 | 2023-12-31 | $-1.60 | $-1.04 |
| 2023-11-09 | 2023-09-30 | $-2.40 | $-1.36 |
| 2023-08-14 | 2023-06-30 | $-3.20 | $-2.88 |
| 2023-05-11 | 2023-03-31 | $-3.20 | $-3.20 |
| 2023-03-20 | 2022-12-31 | $-3.20 | $-2.88 |
| 2022-11-11 | 2022-09-30 | $-2.40 | $-2.80 |
| 2022-08-12 | 2022-06-30 | $-2.40 | $-2.16 |
| 2022-05-12 | 2022-03-31 | $-1.60 | $-1.76 |
| 2022-03-09 | 2021-12-31 | $-1.60 | $-1.76 |
| 2021-11-12 | 2021-09-30 | $-0.08 | $-1.04 |
| 2021-08-13 | 2021-06-30 | $-0.08 | $-1.04 |
| 2021-05-13 | 2021-03-31 | $-1.72 | $-0.88 |
| 2021-03-09 | 2020-12-31 | $-32.00 | $-16.00 |
| 2020-11-16 | 2020-09-30 | $-28.80 | $-22.40 |
| 2020-08-14 | 2020-06-30 | $-35.20 | $-28.80 |
| 2020-05-07 | 2020-03-31 | $-35.20 | $-26.24 |
| 2020-03-17 | 2019-12-31 | $-8.32 | $127.36 |
| 2019-11-15 | 2019-09-30 | $-9.60 | $-144.64 |
| 2019-08-05 | 2019-06-30 | $-49.92 | $-16.00 |
| 2019-05-22 | 2019-03-31 | -- | $-224.00 |
| 2019-02-12 | 2018-09-30 | -- | $10.88 |